Cargando…

Defining Extended Spectrum β-Lactamases: Implications of Minimum Inhibitory Concentration-Based Screening Versus Clavulanate Confirmation Testing

INTRODUCTION: While the Clinical and Laboratory Standards Institute (CLSI) recommends against routine screening for extended spectrum β-lactamases (ESBLs), knowledge of these data can provide valuable insights regarding epidemiology and drug therapy decisions. The purpose of this study was to compar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sutherland, Christina A., Crandon, Jared L., Nicolau, David P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2015
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675766/ https://www.ncbi.nlm.nih.gov/pubmed/26481506 http://dx.doi.org/10.1007/s40121-015-0094-6

Ejemplares similares

Cefixime and cefixime-clavulanate for screening and confirmation of extended-spectrum beta-lactamases in Escherichia coli
por: Al-Tamimi, Mohammad, et al.
Publicado: (2022)

1060. Impact of Laboratory Cessation of Extended-Spectrum β-Lactamase (ESBL) Reporting on Minimum Inhibitory Concentration (MIC) Distribution Trends and Associated Clinical Outcomes
por: Chiang, Anthony, et al.
Publicado: (2019)

Oral Amoxicillin-Clavulanic Acid Treatment in Urinary Tract Infections Caused by Extended-Spectrum Beta-Lactamase–Producing Organisms
por: Beytur, Ali, et al.
Publicado: (2014)

Evaluation of clinicians’ knowledge and use of minimum inhibitory concentration values
por: Witt, Lucy S, et al.
Publicado: (2021)

Extended-spectrum beta-lactamases screening agar with AmpC inhibition
por: Al Naiemi, N., et al.
Publicado: (2009)

Assessment of the effectiveness of three different cephalosporin/clavulanate combinations for the phenotypic confirmation of extended-spectrum beta-lactamase producing bacteria isolated from urine samples at National Public Health Laboratory, Kathmandu, Nepal
por: Bhandari, Raju, et al.
Publicado: (2016)

Cefepime Therapy for Cefepime-Susceptible Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bacteremia
por: Wang, Ruibin, et al.
Publicado: (2016)

Fecal Carriage of Extended-spectrum Beta-lactamase-producing Enterobacteriaceae in Intensive Care Unit Patients
por: Mulki, Shalini Shenoy, et al.
Publicado: (2017)

Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections Due to Extended-Spectrum Beta-Lactamase (ESBL)-Producing Klebsiella pneumoniae
por: Wilkowski, Piotr, et al.
Publicado: (2023)

Correlation of Minimum Inhibitory Concentration Breakpoints and Methicillin Resistance Gene Carriage in Clinical Isolates of Staphylococcus epidermidis
por: Eftekhar, Fereshteh, et al.
Publicado: (2011)

Vancomycin Minimum Inhibitory Concentration for Methicillin-Resistant Staphylococcus aureus Infections; Is There Difference in Mortality Between Patients?
por: Aminzadeh, Zohreh, et al.
Publicado: (2014)

Prevalence and Risk Factors for Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae Colonization in Intensive Care Units
por: Kim, Young Ah, et al.
Publicado: (2020)

Mutation detection and minimum inhibitory concentration determination against linezolid and clofazimine in confirmed XDR-TB clinical isolates
por: Singh, Kamal, et al.
Publicado: (2022)

Epidemiological Analysis of Extended-Spectrum Beta-Lactamase-Producing Bacterial Infections in Adult Live Donor Liver Transplant Patients
por: Singh, Ajeet, et al.
Publicado: (2018)

Evaluation of urine concentrations of amoxicillin and clavulanate in cats
por: KuKanich, Kate, et al.
Publicado: (2020)

Community Transmission of Extended-Spectrum β-Lactamase
por: Mirelis, Beatriz, et al.
Publicado: (2003)

Single-dose amikacin plus 7 days of amoxicillin/clavulanate to treat acute cystitis caused by extended-spectrum beta-lactamase-producing Escherichia coli: A retrospective cohort study
por: Ahn, Sun Tae, et al.
Publicado: (2021)

Extended spectrum beta-lactamases in Eschericia coli isolated from community-acquired urinary tract infections in the Gaza Strip, Palestine
por: Astal, Z., et al.
Publicado: (2004)

Resistance to ceftazidime-avibactam in a KPC-2–producing Klebsiella pneumoniae caused by the extended-spectrum beta-lactamase VEB-25
por: Findlay, Jacqueline, et al.
Publicado: (2023)

Characterisation of genes encoding for extended spectrum β-lactamase in Gram-negative bacteria causing healthcare-associated infections in Mwanza, Tanzania
por: Mwakyabala, Jenipher G., et al.
Publicado: (2023)

In vivo efficacy of humanized high dose meropenem and comparators against Pseudomonas aeruginosa isolates producing verona integron-encoded metallo-β-lactamase (VIM)
por: Ghazi, Islam M., et al.
Publicado: (2016)

Phosphate Promotes the Recovery of Mycobacterium tuberculosis β-Lactamase from Clavulanic Acid Inhibition
por: Elings, Wouter, et al.
Publicado: (2017)

Duration of Colonization by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Healthy Newborns and Associated Risk Factors: A Prospective Cohort Study
por: Rodríguez-Revuelta, María Jesús, et al.
Publicado: (2018)

Identification of a Cluster of Extended-spectrum Beta-Lactamase–Producing Klebsiella pneumoniae Sequence Type 101 Isolated From Food and Humans
por: Aguilar-Bultet, Lisandra, et al.
Publicado: (2020)

The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of silver nanoparticles against Staphylococcus aureus
por: Parvekar, Prashik, et al.
Publicado: (2020)

Novel Extended-spectrum β-Lactamase in Shigella sonnei
por: Lefort, Agnes, et al.
Publicado: (2007)

Extended-spectrum β-lactamases in Gram Negative Bacteria
por: Rawat, Deepti, et al.
Publicado: (2010)

Extended spectrum beta lactamase peritonitis: Time for innovation?
por: Sinha, R., et al.
Publicado: (2012)

Extended spectrum beta-lactamase urinary tract infections
por: Aboumarzouk, Omar M.
Publicado: (2014)

Extended spectrum beta lactamase peritonitis: Our experience
por: Cavoli, G. L., et al.
Publicado: (2013)

In Silico Analysis of Extended-Spectrum β-Lactamases in Bacteria
por: Mlynarcik, Patrik, et al.
Publicado: (2021)

Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities
por: Husna, Asmaul, et al.
Publicado: (2023)

Fluoroquinolone Can Be an Effective Treatment Option for Acute Pyelonephritis When the Minimum Inhibitory Concentration of Levofloxacin for the Causative Escherichia coli Is ≤16 mg/L
por: Kim, Yeonjae, et al.
Publicado: (2021)

Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli Infections in Metro Detroit: Early Dominance of the ST-131 Clone
por: Mills, John P., et al.
Publicado: (2020)

Metallo-β-Lactamase and Extended-Spectrum-β-Lactamase Production by Serratia Strains [Letter]
por: Singh, Bhoj R, et al.
Publicado: (2020)

Two β-Lactamase Variants with Reduced Clavulanic Acid Inhibition Display Different Millisecond Dynamics
por: Elings, Wouter, et al.
Publicado: (2021)

DRESS induced by amoxicillin-clavulanate in two pediatric patients confirmed by lymphocyte toxicity assay
por: Dhir, Arun, et al.
Publicado: (2021)

2805. Extended-Infusion versus Intermittent-Infusion Piperacillin/tazobactam for High Minimum Inhibitory Concentration Pseudomonas aeruginosa Infections
por: Shifko, Carlee R, et al.
Publicado: (2023)

Potassium clavulanate
por: Fujii, Kotaro, et al.
Publicado: (2010)

Determination of minimum inhibitory and minimum bactericidal concentrations of Brazilian strains of Leptospira spp. for streptomycin sulphate
por: Rocha, Bruno Ribeiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2ans1emg0pv46aq6qr8kmpb3mq